Results 161 to 170 of about 109,866 (249)

Trial of Preemptive Pharmacogenetic Testing in Underserved Patients (TOPP UP): Study Framework and Baseline Characteristics of Randomized Controlled Trial Participants

open access: yesClinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Research in pharmacogenetics has advanced over the years, but its broad clinical implementation remains limited. While medically underserved patients may particularly benefit from preemptive pharmacogenetic testing, its clinical impact in this population has not been well explored.
Angel M. Miranda   +13 more
wiley   +1 more source

Can the EU Move ‘Beyond GDP’?

open access: yesJCMS: Journal of Common Market Studies, Volume 64, Issue 2, Page 491-510, March 2026.
Abstract Since 2007, the European Union has devoted significant time and energy to the production and dissemination of new statistics designed to monitor social and environmental trends of various types. These initiatives have often been presented as part of a broader ‘beyond GDP agenda’, which challenges the centrality of economic growth, as measured ...
Christopher Holmes, Agnieszka Widuto
wiley   +1 more source

SuDSlab: Delivering Real‐Time Data on Sustainable Drainage Systems (SuDS)

open access: yesJournal of Flood Risk Management, Volume 19, Issue 1, March 2026.
ABSTRACT Sustainably managing water is a global issue, with rapid land use change, climate change and ageing infrastructure increasing the risk of flooding. To help mitigate against and manage urban flood risk, Sustainable Drainage Systems (SuDS), along with Low Impact Development (LID), Sponge Cities and Water Sensitive Urban Design (WSUD), have been ...
Wm. Alexander Osborne   +2 more
wiley   +1 more source

Global cancer statistics for children: Two decades of change and projections to 2050

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 2, March/April 2026.
Abstract Reliable, contemporary estimates of the global childhood cancer burden remain scarce, particularly in the post‐coronavirus disease 2019 (COVID‐19) era. By using data from the Global Burden of Disease 2021 and Global Cancer Observatory 2022 projects, the authors evaluated the childhood cancer burden at global, regional, and national levels ...
Wangzhong Li   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy